Literature DB >> 26275874

Roles of the NF-κB Pathway in B-Lymphocyte Biology.

Yoshiteru Sasaki1, Kazuhiro Iwai2.   

Abstract

NF-κB was originally identified as a family of transcription factors that bind the enhancer of the immunoglobulin κ light-chain gene. Although its function in the regulation of immunoglobulin κ light-chain gene remains unclear, NF-κB plays critical roles in development, survival, and activation of B lymphocytes. In B cells, many receptors, including B-cell antigen receptor (BCR), activate NF-κB pathway, and the molecular mechanism of receptor-mediated activation of IκB kinase (IKK) complex has been partially revealed. In addition to normal B lymphocytes, NF-κB is also involved in the growth of some types of B-cell lymphomas, and many oncogenic mutations involved in constitutive activation of the NF-κB pathway were recently identified in such cancers. In this review, we first summarize the function of NF-κB in B-cell development and activation, and then describe recent progress in understanding the molecular mechanism of receptor-mediated activation of the IKK complex, focusing on the roles of the ubiquitin system. In the last section, we describe oncogenic mutations that induce NF-κB activation in B-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26275874     DOI: 10.1007/82_2015_479

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  14 in total

1.  The NLR family pyrin domain-containing 11 protein contributes to the regulation of inflammatory signaling.

Authors:  Kornelia Ellwanger; Emily Becker; Ioannis Kienes; Anna Sowa; Yvonne Postma; Yamel Cardona Gloria; Alexander N R Weber; Thomas A Kufer
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

2.  IKKα-Mediated Noncanonical NF-κB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.

Authors:  Brandon Cieniewicz; Varvara Kirillov; Isabel Daher; Xiaofan Li; Darby G Oldenburg; Qiwen Dong; Julie A Bettke; Kenneth B Marcu; Laurie T Krug
Journal:  J Virol       Date:  2022-04-28       Impact factor: 6.549

Review 3.  B- and T-Cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency.

Authors:  Saba Fekrvand; Shaghayegh Khanmohammadi; Hassan Abolhassani; Reza Yazdani
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

4.  p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB.

Authors:  Vanessa Tatangelo; Gioia Boncompagni; Nagaja Capitani; Ludovica Lopresti; Noemi Manganaro; Federica Frezzato; Andrea Visentin; Livio Trentin; Cosima T Baldari; Laura Patrussi
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

5.  Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells.

Authors:  Emmanuel Derudder; Sebastian Herzog; Verena Labi; Tomoharu Yasuda; Karl Köchert; Martin Janz; Andreas Villunger; Marc Schmidt-Supprian; Klaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-20       Impact factor: 11.205

6.  Differential requirements for the canonical NF-κB transcription factors c-REL and RELA during the generation and activation of mature B cells.

Authors:  Maja Milanovic; Nicole Heise; Nilushi S De Silva; Michael M Anderson; Kathryn Silva; Amanda Carette; Fabiano Orelli; Govind Bhagat; Ulf Klein
Journal:  Immunol Cell Biol       Date:  2016-09-21       Impact factor: 5.126

7.  Tanshinol ameliorates CCl4-induced liver fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κB/IκBα signaling pathway.

Authors:  Rong Wang; Jing Wang; Fuxing Song; Shengnan Li; Yongfang Yuan
Journal:  Drug Des Devel Ther       Date:  2018-05-17       Impact factor: 4.162

Review 8.  Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.

Authors:  Charlotte Lees; Colm Keane; Maher K Gandhi; Jay Gunawardana
Journal:  Br J Haematol       Date:  2019-02-10       Impact factor: 6.998

9.  Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.

Authors:  Wei Wang; Yan Zheng; Jinjing Jia; Changji Li; Qiqi Duan; Ruilian Li; Xin Wang; Yongping Shao; Caifeng Chen; Huling Yan
Journal:  Exp Ther Med       Date:  2017-06-06       Impact factor: 2.447

10.  PTIP chromatin regulator controls development and activation of B cell subsets to license humoral immunity in mice.

Authors:  Dan Su; Stijn Vanhee; Rebeca Soria; Elin Jaensson Gyllenbäck; Linda M Starnes; Martina Kubec Højfeldt; Gabriel K Pedersen; Joan Yuan; Jeremy A Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.